Lucid Diligence Brief: Thermo Fisher to acquire Clario
Lucid Diligence Brief: Thermo Fisher to acquire Clario Professional audiences…
Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027
Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027 Professional…
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka…
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…
Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration
Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration…
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership…
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC Professional…
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership Professional…
AI in Healthcare and Digital Health Today—October 27, 2025
This weekly roundup of AI in healthcare spans tools, care, and oversight,…
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…


